School of Medicine
Showing 3,921-3,940 of 4,707 Results
-
Peter Michael Sklarin
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Sklarin practices endocrinology at Menlo Medical Clinic. He is a graduate of Harvard College, where he majored in biology. He attended medical school at the University of California, San Francisco, completed his internal medicine residency at Brigham and Women’s Hospital in Boston, and completed his endocrinology fellowship at the University of California, San Francisco.
Dr. Sklarin is board certified in Endocrinology, Diabetes, and Metabolism and treats patients with a wide variety of endocrine disorders. He has special expertise in thyroid ultrasound and ultrasound guided fine-needle aspiration and directs the Menlo Clinic bone density center.
In his free time Dr. Sklarin enjoys spending time with his family, playing tennis, running, biking, swimming, and doing triathlons. -
Jan Skotheim
Professor of Biology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsMy overarching goal is to understand how cell growth triggers cell division. Linking growth to division is important because it allows cells to maintain specific size range to best perform their physiological functions. For example, red blood cells must be small enough to flow through small capillaries, whereas macrophages must be large enough to engulf pathogens. In addition to being important for normal cell and tissue physiology, the link between growth and division is misregulated in cancer.
-
Irina Skylar-Scott
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Skylar-Scott is a board-certified, fellowship-trained cognitive and behavioral neurologist and clinical assistant professor at Stanford University. She is a Diplomate of the American Board of Psychiatry and Neurology as well as the United Council for Neurologic Subspecialties in Behavioral Neurology and Neuropsychiatry.
Her clinical interests include the treatment of cognitive and behavioral impairment due to Alzheimer’s disease, Parkinson’s disease, Lewy body dementia, posterior cortical atrophy, primary progressive aphasia, frontotemporal dementia, vascular dementia, primary age-related tauopathy, and limbic-predominant age-associated TDP-43 encephalopathy, among other disorders of cognition and behavior.
Her research interests include clinical trials for Alzheimer’s disease and how social and intellectual engagement can affect cognition. She has also investigated impaired consciousness in epilepsy and biomarkers for assessing Duchenne muscular dystrophy. Prior to joining Stanford, Dr. Skylar-Scott was a fellow in the Center for Alzheimer’s Research and Treatment (CART) in the Department of Neurology at Harvard Medical School/Brigham and Women’s Hospital. She also completed her undergraduate degree at MIT, her MD at Yale, and her residency at Harvard.
Dr. Skylar-Scott’s work has appeared in Neurology, Alzheimer's Research and Therapy, Pediatric Neurology, the Journal of Ultrasound in Medicine, Muscle & Nerve, and Epilepsia. She also has also been invited to write book chapters on Alzheimer’s disease, normal pressure hydrocephalus, Parkinson’s disease dementia and Lewy body dementia, and the cognitive and psychiatric consequences of neuroimmunological disorders published by Elsevier and McGraw-Hill.
Presentations by Dr. Skylar-Scott have focused on prevention of cognitive decline in at-risk elderly people, cognitive and neuropsychiatric manifestations of Parkinson’s disease, human prion diseases, and other topics. She has presented at meetings held by the American Academy of Neurology (AAN), the American Neurological Association (ANA), and the American Academy of Neuromuscular and Electrodiagnostic Medicine (AANEM).
For her research and scholarship, Dr. Skylar-Scott has earned honors from the American Academy of Neurology (AAN) and the Howard Hughes Medical Institute (HHMI). She was honored to receive the Golseth Young Investigator Award from the American Association of Neuromuscular & Electrodiagnostic Medicine. In addition, she won the Action Duchenne International Conference First Prize Poster for her research in Duchenne muscular dystrophy.
Dr. Skylar-Scott is a member of the American Neurological Association and American Academy of Neurology. Every year, she walks to raise money for Alzheimer's disease and Lewy body dementia. -
Kristen M. Slater, PsyD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Bio“Understanding and appreciating the totality of a person’s experience in the context of a difficult pain condition is vital in helping them heal in a way that respects their body and reduces suffering” states Dr. Kristen Slater, pain psychologist. “With a compassionate interdisciplinary care team in place, I wholeheartedly believe it is possible for anyone and everyone living with pain to pursue a meaningful and valuable life.”
Dr. Kristen Slater earned her Doctorate of Psychology with an emphasis in Behavioral Medicine and Health Psychology from Loma Linda University. She completed her APA-accredited internship at the Southern Arizona VA Health Care System in Tucson, Arizona. It was there that she developed a passion for Pain Medicine after appreciating how much of an impact pain can have in all areas of life and how powerful interdisciplinary treatment of pain can be in improving one’s quality of life. She went on to receive specialized postdoctoral training and completed an APA-accredited Fellowship in Pain Psychology at Stanford University School of Medicine in the Department of Anesthesiology, Division of Pain, in 2014.
Following her training, she was hired as the lead psychologist and Director of Behavioral Medicine and Psychological Services at Comprehensive Spine and Sports Center in Campbell, California for 5 years where she helped create and found their Functional Restoration Program and Pain Psychology Program. She also worked part-time as a Clinical Instructor at Stanford University School of Medicine and in private practice. She transitioned to Stanford full time in 2019 and is currently a Clinical Assistant Professor in the Department of Anesthesiology and Perioperative Pain Medicine. The majority of her time is allocated towards implementing evidence-based clinical practices but she also enjoys being involved in advancing the field through research. She is involved in multiple NIH and PCORI funded clinical trials working to enhance treatment efficacy and accessibility. She is also a faculty member of the "Empowered Relief" team, and is a Master Trainer involved in teaching international workshops to train clinicians to deliver the single-session evidence-based pain relief skills class, (https://empoweredrelief.com).
Outside of work, Dr. Slater enjoys spending time with her family. She enjoys hiking, traveling and visiting her home state of Colorado. -
Maggi Smeal MD
Clinical Instructor, Pediatrics - General Pediatrics
BioMaggi Smeal MD does her clinical work at Gardner Packard Children's Health Care supervising Stanford residents and medical students in urgent care. She is co-director of the Families at the Border Program in Stanford's Center for Innovation in Global Health. Her humanitarian aid work is focused on helping asylum-seeking families in Tijuana who access care at the Refugee Health Alliance clinics ( RHA) . She leads a team of pediatricians, medical students, undergraduate students and community members to support RHA. The team has taught Helping Babies Breathe, a low-resource neonatal resuscitation program, to midwives in Tijuana. She has also brought a Pediatric Emergency Readiness course to providers at RHA clinics and supports the clinic through telemedicine. She is also a member of RHA's pediatric committee. Her global health work has also involved humanitarian aid in the Philippines and Peru. Locally she has worked on mobile health vans to support migrant farm workers and provided educational sessions for clients at LifeMoves Homeless Shelters. Her team's work with Families at the Border has been presented at the Consortium of Universities for Global Health National Conference and the group was awarded the Untold Global Health Story of 2020.
-
Grant M. Smith, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Grant Smith is a palliative care physician and Clinical Assistant Professor of Medicine at the Stanford School of Medicine. He is the medical director of the Stanford Palliative Care Center of Excellence (PCCOE) Community Partnerships Team, and he is the lead for quality improvement in advance care planning in the Division of Primary Care and Population Health. Dr. Smith graduated with a Bachelor of Science in psychology from Duke University. He received his medical degree from Harvard Medical School. He completed residency in internal medicine at the University of California, San Francisco with a focus in primary care, followed by a chief resident year at the Zuckerberg San Francisco General Hospital. He subsequently completed his palliative care fellowship at the University of California, San Francisco. As part of the Stanford faculty, he is an attending on the palliative care inpatient service and as a provider in the outpatient palliative care clinic in Palo Alto.
-
Kendric C. Smith
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsThe photochemistry and radiation chemistry of DNA, the genetic control and biochemical bases of the multiple pathways of DNA repair, and the roles of DNA repair processes in radiation and spontaneous mutagenesis. Over 190 papers have been published on these and related topics.
-
Melody Smith, MD, MS
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Smith is a board-certified, fellowship-trained medical oncologist and hematologist. She is an assistant professor in the Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
She is a physician-scientist who conducts extensive research. She completed a fellowship at the National Institutes of Health (NIH) in the Clinical Research Training (now, the Medical Research Scholars) Program and she was a post-doctoral researcher at Memorial Sloan Kettering Cancer Center. Her research focuses on studies evaluating strategies whereby donor T cells can be administered to improve outcomes following blood and marrow transplant. Specifically, she studies novel treatment strategies using chimeric antigen receptor (CAR) T cell therapy.
Dr. Smith has been invited to present the findings of her research at regional, national, and international conferences. At the Insights in Hematology Conference, she focused on the use of CAR T cells for blood cancers, whereas she presented her investigations on the associations between CAR T cells and the intestinal microbiome at the European Society for Blood and Marrow Transplantation. Further, at the annual meeting of the American Society of Gene & Cell Therapy, she addressed the importance of training scientists from underrepresented populations.
Dr. Smith has co-authored articles on topics within the field of cancer immunology, including cancer immunotherapy, stem cell transplantation, and CAR T cell therapy. Her work has appeared in journals, including Biology of Blood and Marrow Transplantation, Blood Advances, Leukemia, Nature, Nature Immunology, Nature Medicine, and elsewhere.
She serves a peer reviewer for publications in various journals, such as Biology of Blood and Marrow Transplantation, Haematologica, and ImmunoMedicine. She also has co-written chapters in books, including Pocket Oncology, Current Concepts and Controversies in Hematopoietic Cell Transplantation, and Advanced Concepts in Human Immunology: Prospects for Disease Control.
Dr. Smith has also earned numerous honors. The American Society of Hematology, Society for Immunotherapy of Cancer, European Society for Blood and Marrow Transplantation, and many other professional societies and organizations have recognized her achievements as a clinician, researcher, and scholar.
She is a member of the American Society of Hematology (ASH) Subcommittee on Immunotherapy and the co-chair of the Committee on Trainees and Junior Faculty for the American Society of Transplantation and Cellular Therapy (ASTCT). Other positions in service to professional organizations include co-chairing committees and task forces dedicated to promoting diversity among hematology and cell therapy specialists. -
Robert Lane Smith
Professor (Research) of Orthopedic Surgery, Emeritus
Current Research and Scholarly InterestsOur group is interested in the molecular and cell biology underlying bone and cartilage metabolism in health and disease. Normal daily activities are linked to the ability of the articular cartilage to withstand normal joint forces that may reach 5-7 times body weight and bone homeostasis depends on daily mechanical loading histories.
-
Stephanie Melissa Smith
Instructor, Pediatrics - Hematology & Oncology
Current Research and Scholarly InterestsI am involved with clinical research related to cancer survivorship, with a particular focus on late effects of childhood cancer treatments and community partnerships to improve health equity for adolescent/young adult cancer survivors in under-resourced settings.
-
Stephen J Smith
Professor of Molecular and Cellular Physiology, Emeritus
Current Research and Scholarly InterestsStephen Smith remains active in the computational microscopy field and is also currently using data science tools to explore new transcriptomic perspectives on signaling by neuropeptides and other neuromodulators in brains of diverse animal species. These exploration have unearthed evidence for a previous unrecognized ubiquity of local neuropeptide signaling and possible critical involvement of such signaling in memory engram formation.
-
Stephen Smith, MD
Clinical Assistant Professor, Ophthalmology
Current Research and Scholarly InterestsRESEARCH OVERVIEW
Dr. Smith’s primary professional interest is developing solutions for unmet clinical and surgical vitreoretinal needs. Beginning in medical school, one of his primary focuses has been improving treatment outcomes in patients with retinoblastoma (RB). During his second year in medical school Dr. Smith published a manuscript on a novel technique to reduce the risk of tumor spread following intravitreal drug delivery in patients with RB. His work summarizing published data on tumor spread following intravitreal injection therapy (IVT) for RB has resulted in multiple platform presentations at national and international meetings, including an invited lecture at ARVO 2014. The results of this study influenced the growing trend toward broader acceptance of intravitreal chemotherapy in pediatric patients with treatment-resistant retinoblastoma vitreous seeds. A primary active area of research has included studying and publishing on ocular toxicity that results from the use of intravitreal melphalan and other agents for RB. This work, and subsequent publications from leaders in the field, has led to an increased awareness of ocular toxicity caused by injecting chemotherapeutic agents into the eyes of young children. This highlighted the need for toxicity data on additional chemotherapeutic agents for local delivery. To answer this question, Dr. Smith assembled an excellent group of collaborators and consultants, including internationally known experts at Bascom Palmer, Mayo Clinic, and Emory University. As a resident he secured a highly competitive career starter grant from the Knights Templar Foundation and used that funding and the expertise of his collaborators to carry out preclinical ocular toxicity studies of combination intravitreal chemotherapy for RB. His work in RB has led to a broader recognition of the challenges facing patients with RB who receive IVT and has led to a continued search for optimal local injectable therapies for patients with this disease.
INNOVATION HIGHLIGHTS
In addition to his work in retinoblastoma, Dr. Smith has been actively involved in developing technologies to improve outcomes for patients receiving intravitreal injection therapy (IVT) for macular degeneration, diabetic retinopathy, retinal vein occlusions and more. IVT has become the most common procedure performed by retina specialists in the United States, with an estimated 6 million injections given in the United States alone in 2016. Dr. Smith has co-developed technology that simplifies and streamlines the IVT process, removing barriers to treatment and improving patient outcomes. His work in innovation covers pre-clinical and clinical development work, and has given him expertise in diverse subject areas including fundraising, intellectual property portfolio development, team building, and business administration. He is a co-founder of iRenix Medical, a biotechnology and medical device start-up company committed to improving vision through optimization of the IVT process.
Dr. Smith remains dedicated to helping improve and restore vision and quality of life in patients with vitreoretinal disease. He is currently involved in both medical device and pharmaceutical innovation, and serves as a mentor for the Stanford University Biodesign Innovation Course.
